These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1389200)

  • 1. The rational pharmacology of digoxin.
    Heerdt PM; Heerdt ME
    J Clin Anesth; 1992; 4(5):419-35. PubMed ID: 1389200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding digoxin use in the elderly patient.
    Tsang P; Gerson B
    Clin Lab Med; 1990 Sep; 10(3):479-92. PubMed ID: 2253445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some pharmacokinetic and pharmacodynamic interactions between digoxin and gentamicin.
    Staneva-Stoytcheva D; Kristeva E; Prodanova K
    Eur J Drug Metab Pharmacokinet; 1992; 17(1):1-8. PubMed ID: 1323465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some pharmacokinetic and pharmacodynamic interactions between digoxin and gentamicin.
    Staneva-Stoytcheva D; Kristeva E; Prodanova K
    Acta Physiol Pharmacol Bulg; 1991; 17(4):27-36. PubMed ID: 1668708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin as a glycosylated steroid-like therapeutic drug: Recent advances in the clinical pharmacology and bioassays of pharmaceutical compounds.
    Pashazadeh-Panahi P; Hasanzadeh M
    Biomed Pharmacother; 2020 Mar; 123():109813. PubMed ID: 31924598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of pharmacokinetic interactions between moxonidine and digoxin.
    Pabst G; Weimann HJ; Weber W
    Clin Pharmacokinet; 1992 Dec; 23(6):477-81. PubMed ID: 1458765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and interactions of digoxin, theophylline and furosemide in diseases with edema.
    Macolić V; Vrhovac B
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):6-11. PubMed ID: 8444517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
    Lefebvre RA; Bogaert MG; Duprez D
    Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of clinically relevant interactions between rivaroxaban--an oral, direct Factor Xa inhibitor--and digoxin or atorvastatin in healthy subjects.
    Kubitza D; Becka M; Roth A; Mueck W
    J Int Med Res; 2012; 40(5):1688-707. PubMed ID: 23206451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein system as a determinant of drug interactions: the case of digoxin-verapamil.
    Verschraagen M; Koks CH; Schellens JH; Beijnen JH
    Pharmacol Res; 1999 Oct; 40(4):301-6. PubMed ID: 10527640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers.
    Sarich TC; Schützer KM; Wollbratt M; Wall U; Kessler E; Eriksson UG
    J Clin Pharmacol; 2004 Aug; 44(8):935-41. PubMed ID: 15286098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (VI). The current validity of old drugs: digoxin].
    Martín Luengo C; Arribas Jiménez A; Santos Rodríguez I; Castaño Bazo L; Sánchez López JL
    Rev Esp Cardiol; 1994 Nov; 47(11):754-67. PubMed ID: 7800906
    [No Abstract]   [Full Text] [Related]  

  • 14. Digoxin toxicity in the aged. Characterising and avoiding the problem.
    Passmore AP; Johnston GD
    Drugs Aging; 1991; 1(5):364-79. PubMed ID: 1794026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel, a novel antiplatelet agent, and digoxin: absence of pharmacodynamic and pharmacokinetic interaction.
    Peeters PA; Crijns HJ; Tamminga WJ; Jonkman JH; Dickinson JP; Necciari J
    Semin Thromb Hemost; 1999; 25 Suppl 2():51-4. PubMed ID: 10440424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between digoxin and propafenone.
    Calvo MV; Martin-Suarez A; Martin Luengo C; Avila C; Cascon M; Domínguez-Gil Hurlé A
    Ther Drug Monit; 1989; 11(1):10-5. PubMed ID: 2911842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses.
    Peters J; Welker HA; Bullingham R
    Eur J Drug Metab Pharmacokinet; 1999; 24(2):133-40. PubMed ID: 10510740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin in the 1980s.
    Minson RB; McRitchie RJ
    Med J Aust; 1987 Oct; 147(8):403-7, 410. PubMed ID: 3309595
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
    Harder S; Thürmann PA
    Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.